| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Serum leptin levels are associated with bone mass in nonobese women.
|
J Clin Endocrinol Metab
|
2001
|
2.08
|
|
2
|
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial.
|
Am J Med
|
1996
|
2.00
|
|
3
|
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo.
|
J Endocrinol
|
2002
|
1.93
|
|
4
|
Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.
|
J Clin Invest
|
1986
|
1.73
|
|
5
|
Age- and gender-specific rate of fractures in Australia: a population-based study.
|
Osteoporos Int
|
1999
|
1.69
|
|
6
|
The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study.
|
J Bone Miner Res
|
1998
|
1.65
|
|
7
|
Health burden of hip and other fractures in Australia beyond 2000. Projections based on the Geelong Osteoporosis Study.
|
Med J Aust
|
1999
|
1.62
|
|
8
|
Body fat distribution and non-insulin-dependent diabetes: comparison of a fiber-rich, high-carbohydrate, low-fat (23%) diet and a 35% fat diet high in monounsaturated fat.
|
Am J Clin Nutr
|
1996
|
1.60
|
|
9
|
The population burden of fractures originates in women with osteopenia, not osteoporosis.
|
Osteoporos Int
|
2006
|
1.52
|
|
10
|
Oral contraceptives and bone mineral density: A population-based study.
|
Am J Obstet Gynecol
|
2000
|
1.42
|
|
11
|
Fracture rates lower in rural than urban communities: the Geelong Osteoporosis Study.
|
J Epidemiol Community Health
|
2002
|
1.34
|
|
12
|
Identification of incident fractures: the Geelong Osteoporosis Study.
|
Aust N Z J Med
|
1999
|
1.29
|
|
13
|
Femoral neck geometry and hip fracture risk: the Geelong osteoporosis study.
|
Osteoporos Int
|
2005
|
1.15
|
|
14
|
Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35.
|
Am J Hum Genet
|
2001
|
1.14
|
|
15
|
Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study.
|
J Clin Densitom
|
2000
|
1.13
|
|
16
|
Induction of calcitonin receptors by 1 alpha, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells.
|
Endocrinology
|
1988
|
1.13
|
|
17
|
Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption.
|
Endocrinology
|
1994
|
1.07
|
|
18
|
Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight.
|
Med J Aust
|
2001
|
1.04
|
|
19
|
Effects of a multi-component exercise program and calcium-vitamin-D3-fortified milk on bone mineral density in older men: a randomised controlled trial.
|
Osteoporos Int
|
2008
|
1.03
|
|
20
|
Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study.
|
Osteoporos Int
|
2009
|
1.02
|
|
21
|
Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
|
Clin Exp Allergy
|
2005
|
1.00
|
|
22
|
Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number.
|
Bone
|
1996
|
0.97
|
|
23
|
Expression of functional RANK on mature rat and human osteoclasts.
|
FEBS Lett
|
1999
|
0.93
|
|
24
|
Calcium intakes among Australian women: Geelong Osteoporosis Study.
|
Aust N Z J Med
|
2000
|
0.93
|
|
25
|
Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines.
|
J Cell Physiol
|
1999
|
0.91
|
|
26
|
The Taq IA and Ser311 Cys polymorphisms in the dopamine D2 receptor gene and obesity.
|
Diabetes Nutr Metab
|
2003
|
0.91
|
|
27
|
Osteoclasts from human giant cell tumors of bone lack estrogen receptors.
|
Endocrinology
|
1998
|
0.91
|
|
28
|
Reference ranges for bone densitometers adopted Australia-wide: Geelong osteoporosis study.
|
Australas Radiol
|
2004
|
0.90
|
|
29
|
Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men.
|
Osteoporos Int
|
2008
|
0.90
|
|
30
|
Dietary omega-3 fatty acids and depression in a community sample.
|
Nutr Neurosci
|
2004
|
0.89
|
|
31
|
A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111].
|
Endocrinology
|
1991
|
0.89
|
|
32
|
Autoimmune thyroid disease and giant cell arteritis: a review, case report and epidemiological study.
|
Aust N Z J Med
|
1984
|
0.88
|
|
33
|
Lower levels of physical activity in childhood associated with adult depression.
|
J Sci Med Sport
|
2010
|
0.86
|
|
34
|
A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts.
|
Endocrinology
|
1991
|
0.86
|
|
35
|
A classification of anti-heart antibodies: differentiation between heart-specific and heterophile antibodies.
|
Clin Immunol Immunopathol
|
1977
|
0.85
|
|
36
|
Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
|
J Cell Physiol
|
1993
|
0.85
|
|
37
|
Patterns of treatment in Australian men following fracture.
|
Osteoporos Int
|
2010
|
0.85
|
|
38
|
Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo.
|
Endocrinology
|
1997
|
0.84
|
|
39
|
Fracture risk among older men: osteopenia and osteoporosis defined using cut-points derived from female versus male reference data.
|
Osteoporos Int
|
2013
|
0.84
|
|
40
|
Assessment of fracture risk: value of random population-based samples--the Geelong Osteoporosis Study.
|
J Clin Densitom
|
2001
|
0.83
|
|
41
|
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
|
Bone
|
1996
|
0.83
|
|
42
|
Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
|
J Bone Miner Res
|
1993
|
0.83
|
|
43
|
Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase.
|
Endocrinology
|
1987
|
0.83
|
|
44
|
Cell biology of bone.
|
Baillieres Clin Endocrinol Metab
|
1988
|
0.82
|
|
45
|
Effects of calcitonin gene-related peptide on cyclic AMP formation in chicken, rat, and mouse bone cells.
|
J Bone Miner Res
|
1989
|
0.82
|
|
46
|
Associations between measures of adiposity over 10 years and patella cartilage in population-based asymptomatic women.
|
Int J Obes (Lond)
|
2013
|
0.82
|
|
47
|
Bone mineral density is cross sectionally associated with cartilage volume in healthy, asymptomatic adult females: Geelong Osteoporosis Study.
|
Bone
|
2011
|
0.82
|
|
48
|
A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
|
Osteoporos Int
|
2002
|
0.82
|
|
49
|
Dietary composition, body weight, and NIDDM. Comparison of high-fiber, high-carbohydrate, and modified-fat diets.
|
Diabetes Care
|
1995
|
0.81
|
|
50
|
Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses.
|
Clin Exp Allergy
|
2006
|
0.81
|
|
51
|
Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
|
J Clin Endocrinol Metab
|
2001
|
0.81
|
|
52
|
Incident hip fracture and social disadvantage in an Australian population aged 50 years or greater.
|
Bone
|
2010
|
0.80
|
|
53
|
Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone-related protein.
|
J Cell Biochem
|
1994
|
0.80
|
|
54
|
What's new in osteoclast ontogeny?
|
Pathol Res Pract
|
1991
|
0.80
|
|
55
|
Dietary composition affects regional body fat distribution and levels of dehydroepiandrosterone sulphate (DHEAS) in post-menopausal women with Type 2 diabetes.
|
Eur J Clin Nutr
|
1999
|
0.80
|
|
56
|
Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial.
|
Climacteric
|
2005
|
0.78
|
|
57
|
Evidence that failure of osteoid bone matrix resorption is caused by perturbation of osteoclast polarization.
|
Histochem J
|
1998
|
0.78
|
|
58
|
A quantitative cytochemical investigation of osteoclasts and multinucleate giant cells.
|
Histochem J
|
1991
|
0.77
|
|
59
|
Relationship of serum leptin to total and truncal body fat.
|
Clin Sci (Lond)
|
1997
|
0.77
|
|
60
|
RNA synthesis in isolated rat osteoclasts: inhibitory effect of calcitonin.
|
Bone
|
1991
|
0.77
|
|
61
|
Carboxyl-terminal parathyroid hormone-related protein inhibits bone resorption by isolated chicken osteoclasts.
|
J Bone Miner Res
|
1994
|
0.77
|
|
62
|
Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability.
|
Diabet Med
|
1998
|
0.76
|
|
63
|
Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
|
Endocrinology
|
1988
|
0.76
|
|
64
|
Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
|
Semin Arthritis Rheum
|
1994
|
0.76
|
|
65
|
Weight gain may contribute to increased fracture risk in women treated with rosiglitazone.
|
Diabet Med
|
2007
|
0.76
|
|
66
|
Complex shape changes in isolated rat osteoclasts: involvement of protein kinase C in the response to calcitonin.
|
Calcif Tissue Int
|
1997
|
0.76
|
|
67
|
Femoral neck dimensions are unlikely to be associated with age at menarche.
|
Osteoporos Int
|
1999
|
0.75
|
|
68
|
Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone.
|
Bone
|
2003
|
0.75
|
|
69
|
Estimation of 1,25 dihydroxyvitamin D by cytoreceptor and competitive protein binding assays without high pressure liquid chromatography.
|
Clin Endocrinol (Oxf)
|
1985
|
0.75
|
|
70
|
Citalopram and sertraline exposure compromises embryonic bone development.
|
Mol Psychiatry
|
2015
|
0.75
|
|
71
|
Parathyroid hormone radioimmunoassay: the clinical evaluation of assays using commercially available reagents.
|
J Immunoassay
|
1985
|
0.75
|
|
72
|
Fluoride treatment of osteoporosis: cyclical non-blinded or continuous blinded studies?
|
Osteoporos Int
|
1993
|
0.75
|
|
73
|
Fracture thresholds revisited. Geelong Osteoporosis Study.
|
J Clin Epidemiol
|
2002
|
0.75
|
|
74
|
Calcaneal ultrasound reference ranges for Australian men and women: the Geelong Osteoporosis Study.
|
Osteoporos Int
|
2012
|
0.75
|
|
75
|
Biphasic effect of calcitonin on tartrate-resistant acid phosphatase activity in isolated rat osteoclasts.
|
J Bone Miner Res
|
1991
|
0.75
|
|
76
|
Evidence that protein kinase-A, calcium-calmodulin kinase and cytoskeletal proteins are involved in osteoclast retraction induced by calcitonin.
|
Exp Mol Pathol
|
1992
|
0.75
|
|
77
|
Treatment of osteoporosis and Paget's disease.
|
Curr Opin Rheumatol
|
1991
|
0.75
|